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ABSTRACT

Received:

Stress management is becoming very important part of cancer patient care. Chronic
stressors lead to boost tumorigenesis and promote cancer development, recurrence, and
drug resistant leading to poor health outcomes. The Hypothalamic-Pituitary-Adrenal
(HPA) axis, which is activated by stress, also regulates Hypothalamic-Pituitary-Thyroid
(HPT) axis. Stress related changes in immune function and inflammatory response also
leads to reduced immune surveillance resulting in tumorigenesis. This article explores
the hormonal axis impacted by stress and how chronic stress can lead to poor outcome
of a cancer patient.
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Introduction
Stress is a common factor in modern life. So much so, it is
arguable that many have learned to ignore it rather than find
ways to decrease it. The word brings to mind full schedules and
anxiety riddled twilight hours, but what many don’t consider is
the physiological response our body undergoes, especially under
chronic stress. There is little argument against the idea that a
diagnosis of cancer, at any stage, would increase a person’s daily
baseline stress levels. This undoubtedly plays a role in many of the

decisions and conscious thought made in the day-to-day activities
of a newly diagnosed cancer patient, from activity level, to diet, to
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self-education and health literacy. Once again, little thought is given
to the synergistic potential of cancer progression compounded
with chronic stress. While the jury is out on the capability of stress
to induce or initiate tumorigenesis, there is a consensus in the
scientific community that chronic stress can create a physiological
environment conducive to the increased proliferation, migration,
invasion, drug resistance, and recurrence of existing cancer cells.
The pathways and modulators involved are well described and
models have been developed to uncover the multitude of factors
involved in stress mediated cancer progression.
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Stress
Stress in this context exists in an acute phase as well as a chronic
phase. Acute stress may be a useful evolutionary tool, altering the
decision-making process in individuals [1]. However, chronic stress
on the other hand, is a longer standing exposure to stress related
hormones, and can cause an early wear and tear on peripheral
organs and even psychosomatic degradation [2,3]. Factors that
are most often linked to chronic stress range from socioeconomic
factors and standing to physical illness. Health disparities have
been linked to increased occurrence of chronic stress, tying the
individual into a perpetual cycle of stress and inability to address
the stressors, whether health related or economic [4,5]. Allostatic
load, or the cumulative load and effect of chronic stress, has been
directly correlated with heightened inflammatory responses,
increased levels of oxidative stress, and DNA damage [4]. These
outcomes are clear cut pro cancer metastasis factors and are
widely accepted as influences in oncogenesis. Several studies
have indicated significantly higher levels of allostatic load among
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from the hypothalamus, which as its name suggests, stimulates the
release of Adrenocorticotropic Hormone (ACTH) from the anterior
pituitary. ACTH then stimulates the release of glucocorticoids, like
cortisol, known as the stress hormone, from the adrenal cortex [15].
This class of hormone is known for modulating many systems in the
body, including the suppression of the immune system and response,
decrease in metabolism, dysregulation of many homeostatic
functions, inhibition of DNA repair, and apoptotic pathways [2,3].
Figure 1 shows effects of stress hormones on different functions
of body. Cortisol is a key player in stress, whether acute or chronic.
Inversely related to our nocturnal hormone secretions, cortisol is
normally suppressed at night due to a decrease in CRH release from
the hypothalamus. In chronic stress, this decrease may happen
later than intended, or may not happen at all.

minority groups and economically underprivileged peoples, which
may be one facet of the health disparity and underlying prognoses
of minority demographics [4-6].

Mechanisms of Stress It’s impossible to discuss stress without
discourse on the hypothalamic-pituitary-adrenal axis (HPA) and
the Sympathetic Nervous System (SNS). Whether the stress is
psychological or physiological, the HPA axis is the primary route of
influence. The release of the associated hormones in this axis alters
a myriad of homeostatic functions. In an acute setting, this axis
would initiate a response and subside once the stressor had been
sufficiently removed or dealt with. However, it is not uncommon
in today’s world for this axis to remain active, introducing a new
health concern that spans a wide breadth of prevalent health
concerns. Chronic stress has been shown to cause macroscopic
changes in brain structure, dysregulation of the immune system,
atherosclerosis, depression, poor sleep quality, and hypertension,
among other disorders and chronic illnesses [7-10].
With the massive dysregulation of these systems, numerous
tissues begin to elicit the appropriate microenvironment for cell
proliferation, malignancy, and metastasis [11-13]. The HPA and
SNS facilitate these changes through cell mediators like cytokines
and hormones [14]. The cascade of signaling disruptions travels
through a series of organs and metabolic processes which alter the
normal physiological state in which the human body is intended to
reside.

Stress Hormones

The physiological manifestations of stress start with the
hypothalamic-pituitary-adrenal (HPA) axis. Stressors of various
natures induce a release of Corticotropin Releasing Hormone (CRH)
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Figure 1: Schematic showing affects of stress hormones on
different functions of body.
Cortisol also plays a key role in driving insulin resistance, and
as a result is a facet in diabetes mellitus and metabolic syndrome
inset. Flattened diurnal cortisol rhythms, that is, chronic stress
and elevated cortisol rhythms throughout the daytime, have been
associated with poor prognosis and survival several types of
cancer, including lung and breast cancer [16-18]. Those who suffer
from chronic stress have also shown sustained increased levels of
norepinephrine and epinephrine [19,20]. These neurotransmitters
are known to play arole in angiogenesis and vascularization of
tumors, a critical step in the growth and metastasis in cancer
[21,22]. Norepinephrine has also been shown to increase cell
migration in prostate cancer [23], increase proliferation, migration,
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and invasion of pancreatic cancer [24] and invasion of pancreatic
cancer cells [25]. These neurotransmitters showcase the role of the
stress regulated sympathetic nervous system in the progression of
cancer in several tissue types, in-vitro and in-vivo.
The hypothalamic-pituitary-thyroid (HPT) axis has also been
shown to communicate with the HPA axis [26] and the thyroid
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hormones T3 and T4 are able to regulate tumor cell cycle, growth,
and death [27-29]. One study of 30,000 participants over a 9-year
period found that those with primary subclinical hyperthyroidism
had a higher risk of developing cancer, specifically of the lung and
prostate tissues, while hypothyroidism had no significant relation
to cancer risk [30]. Different cancer related mechanisms influenced
predominantly by HPA, and HPT axis are summarized in (Figure 2).

Figure 2: Stress hormones and cancer
Note: Dysregulation of hypothalamic-pituitary-thyroid (HPT) and hypothalamic-pituitary-adrenal (HPA) due to sociobehavioral stress axis leads to cancer development and progression and impact processes such as apoptosis, angiogenesis, cell
survival inhibition, lymphangiogenesis, tumor growth and metastasis.

Stress and Inflammation
One component of chronic stress and increased cortisol levels
is an amplified production of reactive oxygen species [4]. ROS and
the oxidative stress they cause over an extended period can incite
chronic inflammation potentially damaging cellular structure and
cause mutations in otherwise healthy cells [31,32]. Oxidative stress
can increase the levels of transcription factors (i.e. NF-κB, AP-1,
p53, PPAR-γ, and β-catenin/Wnt) and

upregulate genes associated with growth factors, inflammatory
cytokines, chemokines, cell cycle regulatory molecules, and antiinflammatory molecules [33]. It is likely that an individual suffering
from chronic stress with a high allostatic load may have increased
levels of these transcription factors and their associated genes.
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These factors have also been used as biomarkers to identify
chronic inflammation in patients with cervical, non-small cell
lung, and colorectal cancers [34-36]. Chronic stress, and its
eventual facilitation of chronic inflammation can create a highly
suitable environment for mutations and cellular evolution to a
proliferative state than otherwise observed. While inflammation
is a normal immune mediated response to foreign infectious biota,
chronic inflammation, like chronic stress, can cause premature
deterioration in the systems it is affecting.

Stress and Immunity

It is difficult to discuss the impact of inflammation without
discourse on the immune system itself. Stress and stress hormones
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are well known to suppress the immune response and immune cells
throughout the body. While one may normally think of the immune
system in response to an infectious disease, the immune system
plays a critical role in the detection and suppression of malignant
cells. Several classes of immune cells, including tumor-infiltrating
lymphocytes, cytotoxic T-cells, helper T-cells, and natural killer
cells, have all been shown to play a role in elimination of tumor cells
[37]. Therefore, inhibition of the immune response, as is seen in
individuals suffering from chronic stress and high allostatic loads,
can create an environment where the immune system is unable
to maintain its vigilance in cellular maintenance, allowing for
malignant cells to migrate, invade, and eventually proliferate into
secondary tumor sites [38]. Paradoxically, an over-active immune
system can play a paradoxical role in cancer progression and
prognosis.

While chronic stress may inhibit the immune system, chronic
inflammation, secondary to chronic stress, may cause an increased
number of immune-cell infiltrates into tissues, promoting
angiogenesis [39]. Angiogenesis is an imperative process in
the development of tumor development and is correlated with
poor prognosis [40]. The relationship of the immune system and
cancer is contradictory at times, in part due to the wide breadth
of responsibilities the immune system holds in maintaining
homeostasis. With so many factors, classes of cells, transcription
factors, and mechanisms of action, the immune system can both
target cancer cells for destruction prior to metastasis, as well as
promote the microenvironment needed for proliferative cell growth
and tumorigenesis.

Concluding Thoughts

Stress, specifically chronic stress, plays a far-reaching role in
overall health, predisposition to disease, and progression of disease,
well beyond the confines of cancer and the topics covered in this
article. Even long term and potentially hereditary repercussions of
gene expression and epigenetics are affected by the deregulation
of the HPA axis. Current disease models, both in-vitro and in-vivo,
can provide insight into this phenomenon and its interaction with
general human health and advanced stage diseases. While society
has deemed chronic stress to be the norm, and in some cases
even applauded those who suffer from chronic stress as someone
who just “stays busy”, the deleterious effect chronic stress has on
homeostatic functions is much more intertwined with our well
being than most will ascribe. Current and future research in chronic
stress models should aim to elucidate the extent to which chronic
stress, on a psychological, physiological, and molecular level, may
be exacerbating these illnesses. While treating chronic stress may
only be a sidecar to current medical treatments, this research could
potentiate the necessary discussion on reducing levels of stress in a
more meaningful round table of academia and healthcare.

Copyright@ Tripathi MK | Biomed J Sci & Tech Res | BJSTR. MS.ID.005953.

DOI: 10.26717/BJSTR.2021.37.005953

Acknowledgment
The authors would like to thank Dr. Michael Hocker, Dean of
the UTRGV School of Medicine, for his constant administrative and
financial support.

Contributors

JLW and MKT wrote most of the manuscript. MKT, SCC and
VD contributed with editing and manuscript improvements. AV
prepared, MKT and JLW edited the figures. All authors read and
approved the final manuscript.

Funding

Supported by UTRGV SOM Startup funds to MKT, partially
supported by KSA International Collaboration grant, Saudi Arabia to
MKT, and partially by NIH R01204552 to SCC and MKT. Competing
interests: The authors declare that they have no competing
interests.

References

1. Shafiei N, Gray M, Viau V, Floresco SB (2012) Acute stress
induces selective alterations in cost/benefit decision-making.
Neuropsychopharmacology: official publication of the American College
of Neuropsychopharmacology 37: 2194-2209.
2. Dai S, Mo Y, Wang Y, Xiang B, Liao Q, et al. (2020) Chronic Stress Promotes
Cancer Development. Frontiers in oncology 10: 1492.

3. Moreno Smith M, Lutgendorf SK, Sood AK (2010) Impact of stress on
cancer metastasis. Future oncology (London, England) 6(12): 18631881

4. Djuric Z, Bird CE, Furumoto Dawson A, Rauscher GH, Ruffin MT, et
al. (2008) Biomarkers of Psychological Stress in Health Disparities
Research. The open biomarkers journal 1: 7-19.
5. Rodriquez EJ, Kim EN, Sumner AE, Nápoles AM, Pérez Stable EJ (2019)
Allostatic Load: Importance, Markers, and Score Determination in
Minority and Disparity Populations. Journal of urban health: bulletin of
the New York Academy of Medicine 96: 3-11.

6. Jackson JS, Knight KM, Rafferty JA (2010) Race and unhealthy behaviors:
chronic stress, the HPA axis, and physical and mental health disparities
over the lifecourse. American journal of public health 100: 933-939.
7. Mariotti A (2015) The effects of chronic stress on health: new insights
into the molecularmechanisms of brain-body communication. Future
science OA 1(3): Fso23.
8. Yao BC, Meng LB, Hao ML, Zhang YM, Gong T, et al. (2019) Chronic stress:
a critical risk factor for atherosclerosis. The Journal of international
medical research 47(4): 1429-1440.

9. Da Estrela C, McGrath J, Booij L, Gouin JP (2021) Heart Rate Variability,
Sleep Quality, and Depression in the Context of Chronic Stress. Annals of
behavioral medicine: a publication of the Society of Behavioral Medicine
55: 155-164.
10. Bautista LE, Bajwa PK, Shafer MM, Malecki KMC, McWilliams CA, et
al. (2019) The relationship between chronic stress, hair cortisol and
hypertension. International Journal of Cardiology Hypertension 2:
100012.
11. Gout S, Huot J (2008) Role of cancer microenvironment in metastasis:
focus on colon cancer. Cancer microenvironment: official journal of the
International Cancer Microenvironment Society 1(1): 69-83.

29137

Volume 37- Issue 1

DOI: 10.26717/BJSTR.2021.37.005953

12. Kim Fuchs C, Le CP, Pimentel MA, Shackleford D, Ferrari D, et al.
(2014) Chronic stress accelerates pancreatic cancer growth and
invasion: a critical role for beta-adrenergic signaling in the pancreatic
microenvironment. Brain, behavior, and immunity 40: 40-47.

27. Barreiro Arcos ML, Gorelik G, Klecha A, Genaro AM, Cremaschi GA
(2006) Thyroid hormones increase inducible nitric oxide synthase gene
expression downstream from PKC-zeta in murine tumor T lymphocytes.
American journal of physiology Cell physiology 291(2): C327-C336.

14. Guilliams TG, Edwards L (2010) Chronic stress and the HPA axis. The
Standard 9: 1-12.

29. Frick LR, Rapanelli M, Bussmann UA, Klecha AJ, Arcos ML, et al. (2009)
Involvement of thyroid hormones in the alterations of T-cell immunity
and tumor progression induced by chronic stress. Biological psychiatry
65(11): 935-942.

13. Schwartsburd PM (2003) Chronic inflammation as inductor of procancer microenvironment: pathogenesis of dysregulated feedback
control. Cancer 248
metastasis reviews 22(1): 95-102.
15. McEwen BS (2007) Physiology and neurobiology of stress and
adaptation: central role of the brain. Physiological reviews 87(3): 873904.
16. Abercrombie HC, Giese Davis J, Sephton S, Epel ES, Turner Cobb JM,
(2007) Flattened cortisol rhythms in metastatic breast cancer patients.
Psychoneuroendocrinology 29: 1082-92

17. Sephton SE, Lush E, Dedert EA, Floyd AR, Rebholz WN, et al. (2013)
Diurnal cortisol rhythm as a predictor of lung cancer survival. Brain,
behavior, and immunity 30: S163-S170.

18. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D (2000) Diurnal cortisol
rhythm as a predictor of breast cancer survival. Journal of the National
Cancer Institute 92(12): 994-1000.
19. Schmidt C, Kraft K (1996) Beta endorphin and catecholamine
concentrations during chronic and acute stress in intensive care patients.
European journal of medical research 1(11): 528-532.
20. Rupp H, Jacob R (1995) Excess catecholamines and the metabolic
syndrome: should central imidazoline receptors be a therapeutic target?
Medical hypotheses 44(3): 217-225.

21. Hondermarck H, Jobling P (2018) The Sympathetic Nervous System
Drives Tumor Angiogenesis. Trends in cancer 4(2): 93-94.
22. Tilan J, Kitlinska J (2010) Sympathetic Neurotransmitters and Tumor
Angiogenesis-Link between Stress and Cancer Progression. Journal of
oncology, pp. 539706.
23. Barbieri A, Bimonte S, Palma G, Luciano A, Rea D, et al. (2015) The stress
hormone norepinephrine increases migration of prostate cancer cells in
vitro and in vivo. International journal of oncology 47: 527-534.

24. Huang XY, Wang HC, Yuan Z, Huang J, Zheng Q (2012) Norepinephrine
stimulates pancreatic cancer cell proliferation, migration and invasion
via β-adrenergic receptor-dependent activation of P38/MAPK pathway.
Hepato-gastroenterology 59(115): 889-893.

25. Guo G, Chen X, He W, Wang H, Wang Y, et al. (2018) Establishment of
inflammation biomarkers-based nomograms to predict prognosis of
advanced colorectal cancer patients based on real world data. PloS one
13(12): e0208547.
26. Helmreich DL, Parfitt DB, Lu XY, Akil H, Watson SJ (2005) Relation
between the hypothalamic-pituitary-thyroid (HPT) axis and the
hypothalamic-pituitary-adrenal (HPA) axis during repeated stress.
Neuroendocrinology 81(3): 183-192.

ISSN: 2574-1241

DOI: 10.26717/BJSTR.2021.37.005953

28. Hall LC, Salazar EP, Kane SR, Liu N (2008) Effects of thyroid hormones
on human breast cancer cell proliferation. The Journal of steroid
biochemistry and molecular biology 109: 57-66.

30. Hellevik AI, Asvold BO, Bjøro T, Romundstad PR, Nilsen TI, et al. (2009)
Thyroid function and cancer risk: a prospective population study. Cancer
epidemiology, biomarkers & prevention: a publication of the American
Association for Cancer Research, cosponsored by the American Society
of Preventive Oncology 18(2): 570-574.
31. Fang J, Seki T, Maeda H (2009) Therapeutic strategies by modulating
oxygen stress in cancer and inflammation. Advanced drug delivery
reviews 61(4): 290-302.
32. Khandrika L, Kumar B, Koul S, Maroni P, Koul HK (2009) Oxidative
stress in prostate cancer. Cancer letters 282(2): 125-136.

33. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB (2010) Oxidative
stress, inflammation, and cancer: how are they linked? Free radical
biology & medicine 49(11): 1603-1616.

34. Guo K, Ma Q, Wang L, Hu H, Li J, et al. (2009) Norepinephrine-induced
invasion 41. by pancreatic cancer cells is inhibited by propranolol.
Oncology reports 22(4): 825-830.
35. Holub K, Biete A (2019) Impact of systemic inflammation biomarkers on
the survival outcomes of cervical cancer patients. Clinical & translational
oncology: official publication of the Federation of Spanish Oncology
Societies and of the National Cancer Institute of Mexico 21: 836-844.

36. Luo H, Ge H, Cui Y, Zhang J, Fan R, et al. (2018) Systemic Inflammation
Biomarkers Predict Survival in Patients of Early Stage Non-Small Cell
Lung Cancer Treated With Stereotactic Ablative Radiotherapy - A Single
Center Experience. Journal of Cancer 9: 182-188.
37. Loose D, Van de Wiele C (2009) The immune system and cancer. Cancer
biotherapy & radiopharmaceuticals 24(3): 369-376.

38. Reiche EM, Nunes SO, Morimoto HK (2004) Stress, depression, the
immune system, and cancer. The Lancet Oncology 5: 617-625.
39. De Visser KE, Eichten A, Coussens LM (2006) Paradoxical roles of the
immune system during cancer development. Nature reviews Cancer
6(1): 24-37.

40. Saman H, Raza SS, Uddin S, Rasul K (2020) Inducing Angiogenesis, a
Key Stepin Cancer Vascularization, and Treatment Approaches. Cancers
12(5): 1172.

Assets of Publishing with us

Tripathi MK. Biomed J Sci & Tech Res

• Global archiving of articles

Submission Link: https://biomedres.us/submit-manuscript.php

• Authors Retain Copyrights

This work is licensed under Creative
Commons Attribution 4.0 License

• Immediate, unrestricted online access
• Rigorous Peer Review Process
• Unique DOI for all articles

https://biomedres.us/
Copyright@ Tripathi MK | Biomed J Sci & Tech Res | BJSTR. MS.ID.005953.

29138

